AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Jalra-M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

USV Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Jalra-M 50mg/500mg Tablet

Metformin/linagliptin 50mg/500mg tablets manage elevated blood glucose in type 2 diabetes patients. This dual-action medication mitigates serious diabetic complications like nephropathy and vision impairment, potentially lowering cardiovascular event risk. It may be used alone or in conjunction with other antidiabetic therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and other medications. Consuming it with meals minimizes gastrointestinal distress. Consistent daily dosing is crucial for efficacy; discontinue only under physician guidance. Effective blood sugar control prevents future complications. Maintaining your prescribed diet and exercise regimen is essential for managing your diabetes; lifestyle significantly impacts disease control. Common side effects encompass diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; learn its recognition and management. This medication isn't for all individuals. Inform your physician of pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before use. Pregnant or lactating women should seek medical counsel. Interactions with other drugs are possible; disclose all medications for safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Jalra-M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Jalra-M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Jalra-M 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Jalra-M 50mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Jalra-M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the Jalra-M 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Jalra-M 50mg/500mg Tablet works:

Metformin/linagliptin 50mg/500mg tablets combine two distinct anti-diabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Jalra-M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Jalra-M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Medical advice should be sought.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Jalra-M 50mg/500mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Jalra-M 50mg/500mg tablets. Dosage modifications for Jalra-M 50mg/500mg tablets may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid taking Jalra-M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Jalra-M 50mg/500mg Tablet :

Should you forget to take your Jalra-M 50mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Jalra-M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Jalra-M 50mg/500mg Tablet

Jalra-M 50mg/500mg tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Jalra-M 50mg/500mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Patients with known allergies to Jalra-M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Jalra-M 50mg/500mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Jalra-M 50mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these occur, discontinue Jalra-M 50mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Jalra-M 50mg/500mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological issues.
Jalra-M 50mg/500mg tablets are safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Jalra-M 50mg/500mg Tablet
281
MRP 325
13% off